The latest news updates from the 2024 Symposium
A panel of experts on Tuesday offered guidance for patients and clinicians who have questions about the interplay of treatment and nutrition, physical activity, and sexual health.
Melissa B. Davis, PhD, on Thursday addressed the challenges of unraveling social versus biological drivers of racial disparities in cancer outcomes.
Christina Curtis, PhD, MSc, on Wednesday discussed processes that drive cancer progression across various disease stages and molecular subtypes.
Attendees gathered Thursday evening for the inaugural SABCSยฎ Celebration. View photos from the event, which featured live music, dancing, and chances to catch up with colleagues.
Otto Metzger, MD; E. Shelley Hwang, MD, MPH; and Ann H. Partridge, MD, MPH, were among 10 experts reporting results Thursday during the second General Session of the 2024 San Antonio Breast Cancer Symposiumยฎ.
2024 William L. McGuire Memorial Lecture Award recipient Laura J. van โt Veer, PhD, reviewed career milestones, including the invention of the 70-gene MammaPrint lab test, during her address on Wednesday.
Plan your Friday schedule and donโt miss notable items on the program, including the third General Session, a session for pathologists about IHC testing, and a debate on universal germline genetic testing.
The Year in Review and View from the Trenches sessions on Friday afternoon and evening will wrap up this year’s Symposium and set the stage for discussions to come.